Apr 152016
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MA – Blueprint Medicines Corporation (NASDAQ:BPMC), a leader in discovering and developing highly selective kinase medicines for patients with genomically defined diseases, today announced the appointment of Lynn Seely, M.D.

=> Read more

Blueprint Medicines appoints Dr Lynn Seely to the Board of Directors

From:: Blueprint Medicines appoints Dr Lynn Seely to the Board of Directors

 Posted by at 1:00 pm

Sorry, the comment form is closed at this time.

%d bloggers like this: